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Claudia Langenberg 6, Peter Arner 1, Rona J. Strawbridge 7,8,9,10, Ingrid Dahlman 1,*,10ABSTRACT
Objectives: Lipolysis, hydrolysis of triglycerides to fatty acids in adipocytes, is tightly regulated, poorly understood, and, if perturbed, can lead to
metabolic diseases including obesity and type 2 diabetes. The goal of this study was to identify the genetic regulators of lipolysis and elucidate
their molecular mechanisms.
Methods: Adipocytes from abdominal subcutaneous adipose tissue biopsies were isolated and were incubated without (spontaneous lipolysis) or
with a catecholamine (stimulated lipolysis) to analyze lipolysis. DNA was extracted and genome-wide genotyping and imputation conducted. After
quality control, 939 samples with genetic and lipolysis data were available. Genome-wide association studies of spontaneous and stimulated
lipolysis were conducted. Subsequent in vitro gene expression analyses were used to identify candidate genes and explore their regulation of
adipose tissue biology.
Results: One locus on chromosome 19 demonstrated genome-wide significance with spontaneous lipolysis. 60 loci showed suggestive
associations with spontaneous or stimulated lipolysis, of which many influenced both traits. In the chromosome 19 locus, only HIF3A was
expressed in the adipocytes and displayed genotype-dependent gene expression. HIF3A knockdown in vitro increased lipolysis and the
expression of key lipolysis-regulating genes.
Conclusions: In conclusion, we identified a genetic regulator of spontaneous lipolysis and provided evidence of HIF3A as a novel key regulator of
lipolysis in subcutaneous adipocytes as the mechanism through which the locus influences adipose tissue biology.
 2020 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Release of fatty acids through hydrolysis (lipolysis) of triglycerides in fat
cells plays a major role in energy homeostasis. Lipolysis is highly
regulated in a species-specific fashion. In humans, only catechol-
amines and natriuretic peptides have a strong lipolytic action among
hormones as reviewed [1e3]. Human fat cells also have spontaneous
lipolytic activity [1]. Inter-individual variations in lipolysis have impor-
tant clinical impact. Large cross-sectional studies show significant
relationships between high spontaneous or low catecholamine-
stimulated lipolysis and a variety of metabolic conditions such as
obesity and insulin resistance [4e6]. A recent prospective study
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of future development of excess body fat, insulin resistance, and type 2
diabetes/glucose intolerance [7].
There is a strong genetic component to clinical traits of relevance to
lipolysis, including body fat (measured by body mass index, BMI) [8], the
location of stored lipids (asmeasured bywaist-to-hip ratio (WHR) adjusted
for BMI, WHRadjBMI) [9], and circulating triglyceride levels [10]. It is
therefore likely that lipolysis is also regulated, at least in part, by genetic
variations. Indeed, studies of monozygotic twins demonstrated a strong
within-pair resemblance of spontaneous and catecholamine-stimulated
lipolysis [11,12] and we reported that family history of type 2 diabetes
is associated with increased spontaneous adipocyte lipolysis [13]. A
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Original Articlesubcutaneous adipose tissue (SAT), the largest fat depot in the body,
strongly suggests a genetic regulation of fat cell function [14].
To shed new light on the genetic influence on lipolysis, we conducted a
genome-wide association study (GWAS) on 939 subjects from the
GENiAL (GENetics of Adipocyte Lipolysis) cohort with phenotyping of
spontaneous and catecholamine-stimulated lipolysis in SAT.
2. MATERIALS AND METHODS
2.1. Participants
The GENiAL cohort includes 273 men and 718 women whose char-
acteristics are presented in Table 1. The participants were recruited
between 1986 and 2016 by local advertisements for studies to
examine the regulation of fat cell function with a focus on lipolysis. The
recruitment period was extensive due to the labor-intensive method-
ology used for adipocyte analysis (only a few samples a week are
possible); however, a single laboratory and consistent selection and
analysis protocols were employed throughout.
The GENiAL cohort was used to analyze multiple adipose phenotypes,
but all of the participants in this study had undergone baseline ex-
amination in our laboratory and their lipolysis and DNA measurements
were available (Supplementary Fig. 1). A total of 939 study subjects
with adipocyte lipolysis measurements were included. Descriptions of
the study subjects are presented in Table 2. Overall, 57% were obese
(defined as BMI 30 kg/m2). All lived in Stockholm, Sweden. A total of
194 of the participants had type 2 diabetes, hypertension, or dyslipi-
demia alone or in different combinations. None were treated with in-
sulin, glitazones, or glucagon-like peptide analogues. Data on clinical
variables and rates of fat cell lipolysis were published previously [5,6].
The current study was approved by the local committee on ethics and
explained in detail to each subject. Informed consent was obtained
from all of the participants; this was in written form since 1996.
SAT gene expression was studied in 114 women, a subset of the
cohort. This cohort was previously described [15] and contained the
same type of lipolysis data as presented herein. Gene expression ofTable 1 e Demographics of GENiAL cohort.
Men
nonobese obese
lean/obese (n) 177 96
age (years) 46(15) 43(12)
height (cm) 178(10) 181(7)
body weight (kg) 81(10) 125(18
BMI (kg/m2) 25(2) 38(5)
waist (cm) 92(9) 126(13
WHR 0.95(0.06) 1.05(0.0
systolic blood pressure (mm Hg) 129(15) 140(18
diastolic blood pressure (mm Hg) 78(10) 85(12)
plasma total cholesterol (mmol/l) 5.1(1.3) 5.3(1.4
plasma HDL cholesterol (mmol/l) 1.2(0.4) 1.0(0.2
plasma triacylglycerides (mmol/l) 1.70(1.98) 2.33(2.4
plasma nonesterified fatty acids (mmol/l) 0.49(0.17) 0.62(0.2
plasma glycerol (mmol/l) 59.9(27.2) 78.4(29.
fasting plasma glucose (mmol/l) 5.4(1.2) 6.3(2.3
fasting serum insulin (mU/l) 7.8(5.2) 20.5(11.
HOMA-IR 2.01(1.95) 6.02(4.3
Cell volume (pl) 483(157) 821(193
Spontaneous lipolysis (mmol glycerol/2hrs/ESAT) 0.8(0.7) 3.8(2.8
Stimulated lipolysis (mmol glycerol/2hrs/ESAT) 6.6(5.2) 3.6(1.6
Where: obese is defined as BMI>30 kg/m2; Spontaneous lipolysis rate was calculated as glyc
calculated as the quotient of glycerol release at the maximum effective isoprenaline concent
isolated fat cells. continuous variables are presented as mean (sd), groups were compared
adipose tissue corresponding to the region for needle biopsy.
86 MOLECULAR METABOLISM 34 (2020) 85e96  2020 The Author(s). Published by Elsevier GHIF3A was measured in 75 subjects from the GENiAL cohort with
stored frozen abdominal subcutaneous adipocytes isolated as
described below.
2.2. Clinical examination
The participants came to the Karolinska University Hospital’s clinical
research center in the morning after an overnight fast. Height, weight,
and waist-to-hip ratio (WHR) were measured. Body fat content was
measured via bioimpedance. A venous blood sample was obtained for
extraction of DNA and clinical chemistry, which was performed by the
hospital’s accredited routine clinical chemistry laboratory. HOMA-IR as
measure of systemic insulin resistance was calculated from the fasting
levels of glucose and insulin as previously described [16]. SAT was
obtained via needle aspiration biopsy lateral to the umbilicus as pre-
viously described [17]. The estimated abdominal subcutaneous adi-
pose tissue (ESAT) area was calculated using a formula based on WHR,
sex, age, waist circumference, and body fat as previously described
and validated [18].
2.3. Adipose tissue phenotyping
The SAT samples were rapidly rinsed in sodium chloride (9 mg/ml)
before removal of visual blood vessels and cell debris and subse-
quently subjected to collagenase treatment to obtain isolated adipo-
cytes as previously described [19]. Fat cells were incubated as
previously described [19]. In brief, cell suspensions (diluted to 2%
volume/volume) were incubated for 2 h at 37 C with air as the gas
phase in KrebseRinger phosphate buffer (pH 7.4) supplemented with
glucose (8.6 mmol/l), ascorbic acid (0.1 mg/ml), and bovine serum
albumin (20 mg/ml) either without (spontaneous lipolysis) or with
supplementation with synthetic non-selective b-adrenoreceptor
agonist isoprenaline (Hässle, Mölndal, Sweden) at increasing con-
centrations (109-105 mol/l; stimulated lipolysis). The amount of
glycerol, as a measure of lipolysis, was evaluated in an aliquot of
medium at the end of the incubation [20]. This end product of lipolysis,
unlike the other final fatty acid metabolites, is not re-utilized by fatWomen
P nonobese obese P
269 449
0.049 40(13) 41(10 0.4
0.0089 167(6) 166(6) 0.0038
) <0.0001 67(9) 108(17) <0.0001
<0.0001 24(3) 39(5) <0.0001
) <0.0001 84(10) 119(13) <0.0001
5) <0.0001 0.86(0.07) 0.96(0.07) <0.0001
) <0.0001 120(16) 130(16) <0.0001
<0.0001 74(9) 79(10) <0.0001
) 0.33 4.9(1.1) 5.0(1.0) 0.15
) <0.0001 1.6(0.4) 1.2(0.3) <0.0001
9) 0.038 1.06(0.64) 1.52(0.86) <0.0001
1) <0.0001 0.62(0.21) 0.72(0.24) <0.0001
9) <0.0001 81.1(42.6) 116.9(54.1) <0.0001
) 0.0005 5.0(0.7) 5.6(1.4) <0.0001
8) <0.0001 6.2(3.3) 14.7(7.9) <0.0001
1) <0.0001 1.40(0.87) 3.82(2.88) <0.0001
) <0.0001 473(177) 860(180) <0.0001
) <0.0001 1.0(0.9) 3.3(2.9) <0.0001
) <0.0001 9.1(6.4) 5.8(7.0) <0.0001
erol release divided by the lipid weight of the incubated fat cells; Stimulated lipolysis was
ration divided by the spontaneous rate (no hormone present) of glycerol release from the
with Student’s t-test (unpaired). ESAT is estimated amount of abdominal subcutaneous
mbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Table 2 e Descriptions of the GENiAL participants included in this study.
Men Women
nonobese obese P nonobese obese P
lean/obese (n) 89 163 245 442
age (years) 47(15) 43(13) 0.044 40(13) 41(10) 0.7
height (cm) 178(6) 181(7) 0.0049 167(6) 166(6) 0.0076
body weight (kg) 80(10) 125(18) <0.0001 67(9) 108(17) <0.0001
BMI (kg/m2) 25(2) 38(5) <0.0001 24(3) 39(5) <0.0001
waist (cm) 92(9) 126(13) <0.0001 84(10) 119(13) <0.0001
WHR 0.95(0.06) 1.05(0.05) <0.0001 0.86(0.07) 0.96(0.07) <0.0001
systolic blood pressure (mm Hg) 129(15) 140(19) <0.0001 120(16) 130(16) <0.0001
diastolic blood pressure (mm Hg) 79(10) 85(12) <0.0001 74(10) 80(10) <0.0001
plasma total cholesterol (mmol/l) 5.1(1.3) 5.3(1.4) 0.43 4.9(1.1) 5.0(1.0) 0.29
plasma HDL cholesterol (mmol/l) 1.2(0.4) 1.0(0.2) <0.0001 1.6(0.4) 1.2(0.3) <0.0001
plasma triacylglycerides (mmol/l) 1.70(2.03) 2.32(2.53) 0.047 1.07(0.64) 1.52(0.87) <0.0001
plasma nonesterified fatty acids (mmol/l) 0.49(0.17) 0.61(0.21) 0.0002 0.63(0.21) 0.72(0.24) <0.0001
plasma glycerol (mmol/l) 60.0(27.0) 76.8(27.3) <0.0001 81.9(43.2) 116.8(53.8) <0.0001
fasting plasma glucose (mmol/l) 5.4(1.2) 6.4(2.3) 0.0006 5.0(0.7) 5.6(1.4) <0.0001
fasting serum insulin (mIE/l) 7.8(5.3) 20.5(12.0) <0.0001 6.2(3.4) 14.7(7.9) <0.0001
HOMA-IR 2.01(1.98) 6.05(4.41) <0.0001 1.40(0.88) 3.80(2.88) <0.0001
cell volume (pl) 495(154) 812(193) <0.0001 475(177) 861(179) <0.0001
Spontaneous lipolysis (mmol glycerol/2hrs/ESAT) 0.8(0.7) 3.9(2.8) <0.0001 1.0(0.9) 3.4(2.9) <0.0001
Stimulated lipolysis (mmol glycerol/2hrs/ESAT) 6.6(5.2) 3.6(1.6) <0.0001 9.1(6.4) 5.8(7.0) <0.0001
Where: obese is defined as BMI>30 kg/m2; Spontaneous lipolysis rate was calculated as glycerol release divided by the lipid weight of the incubated fat cells; Stimulated lipolysis was
calculated as the quotient of glycerol release at the maximum effective isoprenaline concentration divided by the spontaneous rate (no hormone present) of glycerol release from the
isolated fat cellscontinuous variables are presented as mean (sd), groups were compared with Student’s t-test (unpaired).cells. The spontaneous lipolysis rate was calculated as the glycerol
release to the incubation medium divided by the lipid weight of the
incubated fat cells. There was no consensus how to express the
lipolysis rates (absolute terms, relative terms, per cell number, or per
lipid weight). We expressed isoprenaline-stimulated lipolysis as the
quotient of glycerol release at the maximum effective isoprenaline
concentration divided by the spontaneous rate (no hormones present)
of glycerol release from the isolated fat cells. Spontaneous lipolysis
was expressed as glycerol release/cell weight multiplied by the weight
of ESAT, that is, an estimate of the total release of glycerol from the
ESAT area. The values were log10 transformed to improve normality
(required for linear regression analysis). These modes of expression
were preferred as they in linear regression showed better correlations
with clinical parameters in the cohort than other ways of expressing
lipolysis (results not shown). Previous in vitro studies demonstrated
that spontaneous and isoprenaline-stimulated lipolysis were linear for
at least 4 h in human subcutaneous fat cells [21].
2.4. Genetic analysis
DNA was extracted from whole blood using standard protocols. The
samples were genotyped using the UK Biobank Axiom Array r3 plat-
form and called using the Axiom analysis suite (https://assets.
thermofisher.com/TFS-Assets/LSG/manuals/axiom_genotyping_
solution_analysis_guide.pdf). Samples were excluded for cryptic
relatedness, ambiguous sex, or low call rates (<95%). Multi-
dimensional scaling, which essentially measures how genetically
similar any two individuals are, was conducted in PLINK (http://zzz.
bwh.harvard.edu/plink/download.shtml) [22] and the principal com-
ponents (PCs) calculated for all individuals. PCs 1e4 were plotted and
population outliers were excluded by visual inspection. SNPs were
excluded for low call rates (<95%), failing HardyeWeinberg equilib-
rium (P< 5 106), or low minor allele frequency (MAF< 1%). After
quality control, imputation was performed using the haplotype refer-
ence consortium panel and, when variants were not available, the
1000G phase 3 reference panel [23]. Post-imputation quality controlMOLECULAR METABOLISM 34 (2020) 85e96  2020 The Author(s). Published by Elsevier GmbH. This is
www.molecularmetabolism.comexcluded SNPs with minor allele counts <3 and INFO <0.4 as well as
related individuals (one of each pair of first- or second-degree rela-
tives). After quality control, 885 samples and 9,260,588 SNPs were
available for phenotypic analysis.
As previously noted, the spontaneous and stimulated lipolysis mea-
surements were log10 transformed prior to statistical analysis. A GWAS
was conducted in PLINK [22], using linear regression assuming an
additive genetic model and adjusting for population structure (PCs1-3),
age, sex, and BMI. BMI was adjusted for as the sample size precluded
separate analysis in obese and non-obese individuals. Genome-wide
significance was set at P < 5  108 and suggestive significance
was set at P < 1  105. Only SNPs with MAF>1% were included in
the results. SNPs were assigned to loci using the independent-pairwise
function in PLINK [22] with default settings. Heritability was calculated
using LD score regression (LDSR) [24].
2.5. Data mining
To identify SNPs with potentially functional effects on nearby genes,
SNPs meeting the threshold for suggestive significance were assessed
using the variant effect predictor (VEP) [25] and ANNOVAR [26] soft-
ware. To identify genotype-specific gene expression patterns or eQTLs,
SNPs reaching GWAS significance or those predicted by VEP or
ANNOVAR to have functional effects were explored using GTEx [27].
2.6. Adipocyte cell culture and transfection with small interfering
RNA
Isolation, growth, and differentiation of SAT-derived human mesen-
chymal stem cells (hMSCs) were previously described [28]. Marker
gene expression (Cap analysis gene expression [CAGE] and qPCR data)
and lipid accumulation images for these cells were previously pub-
lished [29].
hMSCs were transfected using a Neon electroporator (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s protocol. Briefly, 1
million of hMSCs at day 1 of differentiation were mixed with 40 nM ON-
TARGETplus SMARTpool small interfering RNAs (siRNAs) targetingan open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 87
Table 3 e Associations between adipocyte spontaneous or stimulated
lipolysis and systemic metabolic variables.
Spontaneous
lipolysis
Stimulated
lipolysis
Standardized
beta
P Standardized
beta
P
plasma triglycerides
(mmol/l)
0.30 9.0  1019 0.24 3.0  1014
plasma nonesterified
fatty acids
(mmol/l)
0.22 5.3  109 0.07 0.049
plasma glycerol
(mmol/l)
0.22 2.0  1012 0.12 1.0  104
fasting serum
insulin (mU/l)
0.57 4.0  1071 0.38 2  1031
HOMAIR 0.56 3.0  1067 0.38 1.0  1031
Spontaneous lipolysis rate was calculated as glycerol release divided by the lipid
weight of the incubated fat cells; Stimulated lipolysis was calculated as the quotient of
glycerol release at the maximum effective isoprenaline concentration divided by the
spontaneous rate (no hormone present) of glycerol release from the isolated fat cells;
Analysis was performed using multiple regression adjusting for age, and sex.
Original ArticleHIF3A or non-targeting siRNA pool (Dharmacon, Lafayette, CO, USA)
and electroporated using a 100 ml Neon electroporation tip. Electro-
poration conditions were 1600 V, 20 ms width, and 1 pulse. Electro-
poration was repeated until the required amount of cells were collected
for the experimental design. Following electroporation, the cells were
plated in antibiotic-free medium at a density of 120,000 cells/well in
24-well plates or 12,000 cells/well in 96-well plates and cultured until
days 6e13 of differentiation. The medium was collected at days 10
and 13 of differentiation for glycerol measurements as previously
described [30]. The amounts of glycerol were normalized to the
number of nuclei in each well (see “Quantification of neutral lipids and
cell numbers during adipogenesis”).
For HIF3A protein analysis, hMSCs were reverse transfected 24 h
before induction of adipogenesis using ON-TARGETplus SMARTpool
siRNAs targeting HIF3A or non-targeting siRNA control #1 (Dharmacon)
as previously described [31]. In this experimental design, the RNA and
medium were collected at days 2, 6, and 9 after the induction of
differentiation. Lipid accumulation was evaluated at day 9. For pro-
teins, cells were collected 72 h post-transfection.
2.7. Quantification of neutral lipids and cell numbers during
adipogenesis
Lipid accumulation was quantified at differentiation days 10 and 13.
hMSCs differentiated in vitro were washed with PBS and fixed with 4%
paraformaldehyde solution for 10 min at room temperature. The fixed
cells were subsequently washed with PBS and stained with BODIPY
493/503 (0.2 mg/mL; Molecular Probes, Thermo Fisher Scientific) and
Hoechst 33,342 (2 mg/mL; Molecular Probes) for 20 min at room
temperature. Accumulation of intracellular lipids (BODIPY) and cell
numbers (Hoechst) were quantified with a CellInsight CX5 High Content
Screening (HCS) Platform (Thermo Fischer Scientific) using integrated
protocols. Total BODIPY fluorescence (lipid droplets) was normalized to
the number of nuclei in each well.
2.8. Isolation of RNA and analysis of gene expression
The hMSCs were collected at days 6, 10, and 13 of differentiation for
isolation of RNA. Extraction of total RNA, measurement of concentration
and purity, and reverse transcription were performed as previously
described [30]. Isolation of RNA from frozen abdominal subcutaneous
adipocytes was conducted as previously described [15]. Quantitative
RT-PCR of the coding genes was performed using commercial TaqMan
probes (Applied Biosystems, Foster City, CA, USA). Gene expression was
normalized to the internal reference gene 18s. Relative expression was
calculated using the 2 (DD threshold cycle) method [32].
2.9. Analysis of protein expression
The hMSCs were transfected with siRNA against HIF3A 24 h prior to
the induction of differentiation as previously described. At 72 h post-
transfection, the cells were collected to isolate cytosolic and nuclear
fractions as previously described [33]. Nuclei obtained from approxi-
mately 500,000 cells were analyzed in 150 mL of radio-
immunoprecipitation assay buffer (Perce/Thermo Fisher)
supplemented with 5 mM of NaF, 1 mM of Na3VO4, protease inhibitor
cocktail set V (Calbiochem), and benzonase (SigmaeAldrich) on ice for
30 min. Cytosolic proteins were clarified by centrifugation at
14,000 rpm for 30 min. The nuclear and cytosolic proteins were
separated by 10% Mini-PROTEAN TGX Stain-Free Precast Gels (Bio-
Rad) allowing direct protein visualization in the gels and after transfer
onto the membranes. Protein transfer to the PVDF membranes was
performed using a Trans-Blot Turbo Transfer System (Bio-Rad). The
membranes were blocked in 3% ECL Advance Blocking Agent (GE88 MOLECULAR METABOLISM 34 (2020) 85e96  2020 The Author(s). Published by Elsevier GHealthcare, Little Chalfont, UK). Antibodies against HIF3A were ob-
tained from Proteintech (Rosemont, IL, USA) and Prosci (Poway, CA,
USA), both used at 1:1000 dilution. Secondary rabbit IgG-horseradish
peroxidase antibodies were obtained from SigmaeAldrich. Antibody
antigen complexes were detected by chemiluminescence using an ECL
Select Western Blotting Detection Kit (GE Healthcare) in Chemidoc MP
(Bio-Rad) and quantified using Image Lab software (Bio-Rad). Total
lysate from Hep2D cells (Novus Biologicals, Abingdon, UK) was used as
a positive control for HIF3A antibodies.
2.10. Statistical analysis of clinical and in vitro data
The values of clinical variables and results of the in vitro experiments
are mean  standard deviation (SD). Lipolysis, glycerol, and triglyc-
eride values were normalized by log10 transformation prior to analysis.
Standard statistical tests were used including the t-test and single or
multiple regression as indicated in the figure/table legends using
StatView software (Abacus Concepts Inc, Berkley, CA, USA) or JMP 13
(SAS, Cary, NC, USA).
3. RESULTS
Demographic characteristics of all of the participants in the GENiAL
cohort are presented in Table 1 and those analyzed in the GWAS are
presented in Table 2. The GWAS cohort consisted predominantly of
women who were younger and had a higher frequency of obesity than
the men. Obesity was associated with higher systemic levels of fasting
lipids, glucose, and insulin levels in both genders. Spontaneous lipol-
ysis, measured as the rate of glycerol release from a defined segment of
abdominal subcutaneous adipose tissue, was higher in the obese
subjects. The stimulated lipolysis, measured as catecholamine-induced
divided by basal glycerol release in isolated fat cells, was lower among
the obese subjects. As expected, spontaneous and stimulated lipolysis
were inversely correlated to one another (R2 ¼ 0.49, standardized
beta 0.70, p ¼ 1  10134).
To assess in vivo relevance, spontaneous and stimulated lipolysis mea-
sures were assessed for association with systemic metabolic variables
(Table 3). Spontaneous lipolysis was positively correlated with the fasting
plasma levels of triglycerides, free fatty acids, insulin, and HOMA-IR as
measures of systemic insulin resistance after adjusting for age and sexmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1: Results of the GWAS of spontaneous and stimulated lipolysis. QQ and Manhattan plots for A) spontaneous lipolysis and B) isoprenaline-stimulated lipolysis. In the QQ
plot, the red dotted line indicates the null distribution. In the Manhattan plot, the horizontal red line represents the threshold for GWAS significance (P < 5  108).(Table 3). For the triglycerides, insulin, and HOMA-IR, the results
remained significant after adjusting to BMI (results not shown).
3.1. GWAS of spontaneous and stimulated lipolysis
The results are presented in Figure 1 and Supplementary Tables 1 and 2 A
total of 112 SNPs in 25 loci demonstrated suggestive associations
(P < 1  105) with spontaneous lipolysis (Figure 1A, Table 4, and
Supplementary Table 1), including one that demonstrated GWAS-MOLECULAR METABOLISM 34 (2020) 85e96  2020 The Author(s). Published by Elsevier GmbH. This is
www.molecularmetabolism.comsignificant (P < 5  108) associated SNPs on chromosome 19. Many
geneswerepotentially impactedby theSNPs in this regionof chromosome
19 (Figure 2A). For stimulated lipolysis (Figure 1B), 156 SNPs in 40 loci
reached the threshold for suggestive association (Table 4 and
Supplementary Table 2); however, no GWAS-significant signals were
identified.Thesamplesizeprecludedanalysis stratifyingbyobesity status.
However sensitivity analysis of the GWAS-significant signals demon-
strated consistent directions, but weaker effects in the obese vs non-an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 89
Table 4 e GWAS-significant and suggestive loci for spontaneous lipolysis and suggestive loci for stimulated lipolysis.
Spontaneous lipolysis Stimulated lipolysis
Chr Pos SNP Ref Alt Freq N Beta Se L95 U95 P N Beta Se L95 U95 P
1 44208924 1:44208924_D_I I D 0.85 856 0.144 0.029 0.088 0.200 5.48E-07 874 0.076 0.022 0.118 0.033 0.0006
1 161567916 rs371656041 C T 0.99 856 0.449 0.095 0.263 0.636 2.64E-06 874 0.300 0.069 0.434 0.165 1.44E-05
1 229572764 rs145251747 D I 0.98 856 0.429 0.091 0.250 0.608 3.13E-06 874 0.257 0.070 0.394 0.120 0.0003
2 87271929 rs71226525 T G 0.54 856 0.097 0.020 0.057 0.137 2.16E-06 874 0.046 0.015 0.076 0.016 0.0027
2 170578879 rs369684581 A G 0.83 856 0.108 0.024 0.061 0.156 9.60E-06 874 0.056 0.018 0.092 0.020 0.0026
2 172907753 rs60231166 T C 0.74 856 0.121 0.023 0.076 0.166 1.74E-07 874 0.055 0.017 0.090 0.021 0.0016
3 67430871 rs73098354 G A 0.98 856 0.266 0.060 0.383 0.150 8.80E-06 874 0.192 0.045 0.103 0.280 2.63E-05
4 94856317 rs2918080 G T 0.78 856 0.096 0.021 0.138 0.054 8.80E-06 874 0.039 0.016 0.007 0.071 0.0164
5 14637275 rs138114267 A C 0.98 856 0.285 0.063 0.162 0.408 6.27E-06 874 0.204 0.047 0.297 0.111 1.92E-05
5 32955093 rs114601412 T C 0.95 856 0.176 0.039 0.100 0.253 7.70E-06 874 0.148 0.030 0.206 0.090 6.64E-07
6 6326042 rs9502434 A G 0.96 856 0.194 0.043 0.110 0.278 6.63E-06 874 0.129 0.033 0.192 0.065 8.72E-05
6 44053018 rs554214639 D I 0.85 856 0.111 0.024 0.158 0.063 6.38E-06 874 0.065 0.018 0.028 0.101 0.0005
8 133340555 rs111301880 T C 0.97 856 0.278 0.061 0.158 0.398 6.63E-06 874 0.206 0.045 0.295 0.116 6.90E-06
12 53131676 rs11170254 T C 0.09 856 0.141 0.032 0.203 0.079 9.83E-06 874 0.112 0.024 0.065 0.160 3.86E-06
13 71658551 rs144654648 T C 0.99 856 0.389 0.086 0.221 0.556 6.58E-06 874 0.214 0.065 0.342 0.087 0.0010
13 74083355 rs117619390 G A 0.98 856 0.293 0.061 0.413 0.173 2.05E-06 874 0.152 0.046 0.063 0.242 0.0009
13 90513818 rs9588787 T C 0.42 856 0.086 0.018 0.121 0.051 1.55E-06 874 0.051 0.014 0.024 0.077 0.0002
13 97727951 rs149528824 G C 0.99 856 0.417 0.089 0.243 0.591 3.17E-06 874 0.228 0.068 0.361 0.094 0.0008
14 19462974 rs28701881 T C 0.99 856 0.478 0.103 0.277 0.680 3.80E-06 874 0.366 0.082 0.526 0.205 8.87E-06
15 68691171 rs199600197 I D 0.11 856 0.171 0.035 0.240 0.102 1.34E-06 874 0.102 0.027 0.050 0.154 0.0001
15 92595793 rs28660218 T C 0.99 856 0.384 0.082 0.223 0.544 3.19E-06 874 0.305 0.062 0.426 0.183 1.15E-06
16 79960721 rs143486974 A G 0.98 856 0.360 0.073 0.217 0.503 9.35E-07 874 0.166 0.056 0.276 0.057 0.0030
18 12923043 rs16939974 C T 0.84 856 0.104 0.023 0.059 0.149 6.08E-06 874 0.075 0.017 0.109 0.041 1.40E-05
19 46633622 rs73048030 A G 0.98 856 0.377 0.066 0.249 0.506 1.20E-08 874 0.197 0.049 0.293 0.101 5.90E-05
19 46635857 rs73048031 C T 0.98 856 0.372 0.067 0.241 0.504 3.82E-08 874 0.197 0.050 0.294 0.099 8.74E-05
1 16291470 rs3979178 A G 0.73 856 0.065 0.019 0.028 0.103 0.0007 874 -0.065 0.014 -0.093 -0.037 7.54E-06
1 72905881 rs7524249 C A 0.80 856 0.078 0.022 0.035 0.120 0.0003 874 -0.076 0.016 -0.107 -0.044 3.39E-06
2 63587155 rs148533396 T C 0.98 856 0.245 0.062 0.124 0.366 8.17E-05 874 -0.218 0.047 -0.310 -0.126 4.10E-06
2 87414589 rs540268296 D I 0.98 856 0.287 0.083 0.124 0.450 0.0006 874 -0.280 0.062 -0.403 -0.158 8.15E-06
2 137306522 rs116525497 G A 0.98 856 0.249 0.060 0.131 0.367 4.08E-05 874 -0.205 0.046 -0.294 -0.115 8.84E-06
2 218934359 rs55703230 T C 0.99 856 0.440 0.100 0.243 0.636 1.32E-05 874 -0.347 0.076 -0.496 -0.198 5.82E-06
2 236618480 rs560405754 A C 0.99 856 -0.282 0.094 -0.466 -0.098 0.0028 874 0.314 0.070 0.177 0.450 7.71E-06
3 2428151 rs1032784 A G 0.75 856 -0.078 0.020 -0.118 -0.038 0.0001 874 0.070 0.015 0.040 0.100 5.51E-06
3 28133397 rs1506686 A C 0.99 856 0.321 0.087 0.150 0.492 0.0003 874 -0.314 0.066 -0.443 -0.184 2.32E-06
3 116686382 rs590225 T C 0.82 856 0.078 0.023 0.033 0.124 0.0008 874 -0.078 0.017 -0.112 -0.044 8.21E-06
4 177130984 rs73007116 G T 0.91 856 0.105 0.033 0.040 0.171 0.0016 874 -0.118 0.025 -0.166 -0.070 1.75E-06
5 14799937 rs114867704 T C 0.97 856 0.246 0.060 0.128 0.363 4.69E-05 874 -0.222 0.044 -0.309 -0.135 6.91E-07
5 66547938 5:66547938_G_A A G 0.96 856 0.157 0.049 0.061 0.253 0.0015 874 -0.190 0.037 -0.262 -0.118 2.76E-07
5 88866702 rs74574939 G T 0.99 856 0.250 0.076 0.101 0.398 0.0010 874 -0.267 0.057 -0.379 -0.154 3.74E-06
5 134881956 rs72787161 T G 0.98 856 0.328 0.074 0.183 0.474 1.04E-05 874 -0.288 0.055 -0.395 -0.180 2.10E-07
6 105831370 rs117269303 T C 0.99 856 0.270 0.076 0.121 0.420 0.0004 874 -0.263 0.056 -0.373 -0.152 3.73E-06
6 123139459 rs35141697 D I 0.75 856 -0.067 0.020 -0.107 -0.028 0.0009 874 0.070 0.015 0.040 0.100 4.94E-06
7 41024130 rs200674393 I D 0.98 856 -0.329 0.077 -0.481 -0.177 2.45E-05 874 0.305 0.059 0.191 0.420 2.29E-07
8 3902830 rs79055631 T G 0.95 856 0.138 0.042 0.057 0.220 0.0009 874 -0.148 0.031 -0.209 -0.086 2.66E-06
8 10375973 rs111818085 I D 0.89 856 0.064 0.027 0.012 0.117 0.0163 874 -0.094 0.020 -0.133 -0.055 2.78E-06
8 13095207 rs7007799 G A 0.87 856 0.094 0.027 0.041 0.146 0.0005 874 -0.094 0.020 -0.133 -0.054 3.45E-06
9 26337144 rs10967318 A G 0.99 856 0.311 0.101 0.112 0.509 0.0023 874 -0.321 0.071 -0.460 -0.181 7.50E-06
10 109418980 rs1902740 T C 0.28 856 0.082 0.019 0.045 0.119 1.49E-05 874 -0.069 0.014 -0.097 -0.042 1.21E-06
11 94458034 rs117762377 A G 0.99 856 -0.174 0.079 -0.328 -0.019 0.0277 874 0.262 0.057 0.150 0.373 4.58E-06
12 14094162 rs148192549 C T 0.99 856 0.238 0.087 0.068 0.408 0.0062 874 -0.304 0.064 -0.429 -0.179 2.11E-06
12 101524071 12:101524071_G_A A G 0.98 856 0.158 0.064 0.032 0.285 0.0143 874 -0.209 0.047 -0.300 -0.117 8.29E-06
12 133262001 rs11147005 T C 0.32 856 0.045 0.019 0.009 0.082 0.0148 874 -0.062 0.014 -0.089 -0.035 7.14E-06
13 30567601 rs142268497 C T 0.99 856 -0.246 0.085 -0.413 -0.080 0.0038 874 0.301 0.064 0.176 0.427 3.00E-06
13 73025966 rs9318075 A G 0.64 856 0.051 0.018 0.016 0.086 0.0041 874 -0.059 0.013 -0.085 -0.033 9.92E-06
16 1595600 rs56342298 T C 0.95 856 0.108 0.039 0.031 0.185 0.0064 874 -0.132 0.029 -0.189 -0.074 7.79E-06
17 73299631 rs9892812 G A 0.47 856 -0.044 0.018 -0.079 -0.009 0.0146 874 0.059 0.013 0.033 0.085 9.79E-06
18 1772503 rs541861443 A T 0.42 856 -0.078 0.019 -0.116 -0.041 4.75E-05 874 0.065 0.014 0.037 0.094 6.62E-06
18 48657387 18:48657387_C_T T C 0.73 856 0.084 0.020 0.045 0.124 3.66E-05 874 -0.074 0.015 -0.104 -0.045 1.21E-06
20 4213175 rs79601367 A G 0.96 856 0.160 0.045 0.071 0.249 0.0005 874 -0.167 0.034 -0.234 -0.099 1.44E-06
22 32335786 rs138027893 A C 0.95 856 0.131 0.040 0.052 0.210 0.0012 874 -0.135 0.030 -0.194 -0.076 8.31E-06
Beta, effect of Alt allele; Freq, frequency of Alt allele; Spontaneous lipolysis rate was calculated as glycerol release divided by the lipid weight of the incubated fat cells multiplied by the
weight of ESAT; Stimulated lipolysis was calculated as the quotient of glycerol release at the maximum effective isoprenaline concentration divided by the spontaneous rate (no
hormone present) of glycerol release from the isolated fat cells. Where SNPs were suggestive for both traits, they are listed under spontaneous lipolysis. The most significant SNP in
each locus i listed in the table.
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Figure 3: Functional validation of HIF3A function in human adipocytes. A) HIF3A gene expression during hMSC differentiation in vitro. Data retrieved from FANTOM5 dataset (http://
fantom.gsc.riken.jp/5/). B) and D-E) Expression of HIF3A was knocked down using siRNA in hMSCs 24 h after induction of differentiation and followed until differentiation days 6,
10, and 13, upon which B) the expression of HIF3A, LIPE, PLIN1, and PNPLA2 was monitored, D) glycerol amount in medium was measured, E) accumulation of neutral lipids was
evaluated, and F) the expression of ADIPOQ and FABP4 was measured. C) The expression of HIF3A was knocked down using siRNA in hMSCs 24 h before induction of adipogenic
differentiation of hMSCs; 72 h post-transfection, the cells were collected, fractionated to the cytosolic and nuclear fraction, and the proteins were analyzed by Western blotting. The
expression of HIF3A was normalized to the total protein amount. Results in B-E are based on four biological/independent experiments. The expression of genes was normalized to
the reference gene 18s. The results were analyzed using t-tests and presented as fold change  SD relative to negative control of a corresponding time point (Neg C). Results in C)
were analyzed using one-sided t-tests and presented as fold change  SD relative to negative control (Neg C). ***P < 0.005, **P < 0.01, *P < 0.05.
Figure 2: Regional plot of the GWAS-significant spontaneous lipolysis-associated locus on chromosome 19. A) Regional plot of the GWAS-significant locus, B) linkage
disequilibrium (LD) of SNPs meeting the threshold for suggestive significance, and C) regional plot after conditional analyses of the GWAS-significant rs73048030 or D)
rs73048031. LD colors and values given in R2.obese individuals (rs73048030: beta¼0.26 Se 0.08 P¼ 2.40 107
vs beta¼0.55 Se¼ 0.10 P¼ 7.46 104, respectively).
There was a strong overlap between SNPs associated with spon-
taneous and stimulated lipolysis; all of the SNPs displayingMOLECULAR METABOLISM 34 (2020) 85e96  2020 The Author(s). Published by Elsevier GmbH. This is
www.molecularmetabolism.comsuggestive associations with spontaneous lipolysis were nominally
associated with stimulated lipolysis (Supplementary Table 1),
whereas 149 of the 156 SNPs displaying suggestive associations
with stimulated lipolysis were nominally associated with spontaneousan open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 91
Figure 4: A) Genotype-specific gene expression for HIF3A, with higher levels observed with 2 copies of rs73048031-C. Gene expression expressed relative to 18 S. Genotype
groups were compared with Student’s t-test. P ¼ 0.076 (two-sided), P ¼ 0.038 (one-sided). B) Relationship between abdominal SAT HIF3A expression and spontaneous lipolysis.
Original Articlelipolysis (Supplementary Table 2). This was expected as spontaneous
and stimulated lipolysis are correlated (inversely) and share several
regulatory steps in signaling to the lipases that ultimately hydrolyze
triglycerides [1e3].
Using LDSR, SNP heritability (observed scale) was estimated as
14.2% (h2SNP ¼ 0.1426; SE ¼ 0.468) for spontaneous lipolysis and
26.4% (h2SNP ¼ 0.264; SE ¼ 0.454) for stimulated lipolysis. Of note,
the summary statistics meta-data for both spontaneous and stimu-
lated lipolysis suggested that the files were not suitable for genetic92 MOLECULAR METABOLISM 34 (2020) 85e96  2020 The Author(s). Published by Elsevier Gcorrelation analyses (the mean chi-square was too low). Given that
the sample size was <1,000 individuals, this was unsurprising.
3.2. Chromosome 19 locus was significantly associated with
spontaneous lipolysis
The genome-wide significant spontaneous lipolysis-associated chro-
mosome 19 locus (Figure 2A) encompasses a region ofw130 Kb that
includes two GWAS-significant SNPs and 68 suggestive SNPs
(Supplementary Table 3). The linkage disequilibrium (LD) betweenmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
www.molecularmetabolism.com
SNPs meeting the threshold for suggestive evidence of association
(Figure 2B) and the non-significant association of these SNPs with
spontaneous lipolysis analyses when conditioning on the GWAS-
significant SNPs, rs73048030 (Figure 2C), or rs73048031
(Figure 2D) demonstrated that this locus contained only one associa-
tion signal (Supplementary Table 3). All of the SNPs in the chromosome
19 locus demonstrating GWAS-significant evidence of association with
spontaneous lipolysis were assessed for potential functional effects
using VEP and ANNOVAR. None of the SNPs were predicted to have
significant or deleterious effects on nearby genes. The most severe
consequence for each SNP is reported in Supplemental Table 4. The
chromosome 19 locus was previously associated with inflammatory
and hematological traits (Supplementary Table 5) [34e40]. This locus
was also previously associated with lipoprotein disorders in UK Bio-
bank (albeit in a caseecontrol analysis with only 51 cases, http://
pheweb.sph.umich.edu/pheno/277.51).
3.3. Expression analysis for chromosome 19 locus candidate gene
identification
All of the transcripts in the chromosome 19 region bordered by a
recombination rate of 25% from the lead SNPs were examined for
expression in publicly available transcriptome data of our human
adipocyte cultures and in isolated mature abdominal adipocytes from
our clinical samples available in the FANTOM5 dataset (http://fantom.
gsc.riken.jp/5/) and [29]. Only HIF3A was expressed in the isolated
mature adipocytes (Supplementary Table 6) and precursor cells, that is
the hMSCs undergoing differentiation to adipocytes (Figure 3A). PPP5C
was expressed in the mature adipocytes but not precursors, so was not
included in further analysis.
We also examined the genotype-dependent gene expression in the
chromosome 19 locus. According to GTEx [27], the genome-wide sig-
nificant SNPs on chromosome 19, rs73048030, and rs73048031 were
eQTLs for IGL3 in the skin, but not for HIF3A in any investigated organ
including the white adipose tissue (Supplementary Table 4). Adipose
tissue comprises different cell types that can mask an eQTL effect on a
single cell type. To test an adipocyte-specific effect of rs73048030 and
rs73048031, we measured HIF3A in the isolated frozen adipocytes from
GENiAL (N ¼ 75). The common allele of rs73048031-C was marginally
associatedwith higher gene expression (P¼ 0.076 two-sided; P¼ 0.038
one-sided) (Figure 4A). Due to the low MAF of rs73048031, no homozy-
gous subject for the rare allele was included in the eQTL analysis. The
results did not remain significant if adjusted for age, sex, and BMI, which
was not surprising given the limited size of our cohort. The results for
rs73048030 were similar although non-significant due to the lower ge-
notype call rate (results not shown). No genotype-specific expression
patterns were identified for PPP5C.
In addition,HIF3A in abdominal SAT in relation to lipolysiswas assessed in
a subset of the study cohort with lipolysis and gene expression mea-
surements (114 women with a wide variation in BMI). HIF3A expression
was inversely correlated with spontaneous lipolysis (Figure 4B). Based on
these findings, HIF3A was further functionally evaluated.
3.4. Effect of candidate gene manipulation on adipose tissue
biology
The expression of HIF3A during differentiation of hMSCs increased at
the very beginning of differentiation, reaching peak expression at day 2
of differentiation and decreasing thereafter to almost the same level as
in the beginning of differentiation (Figure 3A). Based on the high
expression early in differentiation, we knocked down HIF3A usingMOLECULAR METABOLISM 34 (2020) 85e96  2020 The Author(s). Published by Elsevier GmbH. This is
www.molecularmetabolism.comsiRNA in the hMSCs at day 1 and followed the cells to differentiation
days 10 and 13. This resulted in 45e50% decreased HIF3A expression
at days 5, 9, and 12 post-transfection (that is, days 6, 10, and 13 of
differentiation, Figure 3B); thus, approximately 50% of knockdown was
left by the end of differentiation. In contrast, the expression levels of
the genes central to lipolysis (hormone-sensitive lipase (LIPE ), perilipin
1 (PLIN1), and adipose triglyceride lipase (PNPLA2)) increased by
HIF3A knockdown. The expression of LIPE increased by at least
60-40% at days 6 and 10. The expression of PNPLA2 increased by 40,
30, and 15%, respectively, at days 6, 10, and 13. The expression of
PLIN1 increased by w20% at day 10 only (Figure 3B). The effect of
gene silencing naturally gradually diminished due to the long post-
transfection time of almost two weeks. We analyzed the effects of
siRNA on HIF3A protein at day 2 of differentiation due to its highest
expression at the beginning of differentiation. We detected a small but
significant downregulation of HIF3A protein in the nuclear fraction but
not in the cytosolic fraction (Figure 3C).
We further evaluated the glycerol levels in the conditioned medium as a
marker of lipolysis. The glycerol levels increased significantly by
approximately 20-50% at days 10 and 13, respectively (Figure 3D). We
also evaluated the effects on lipid accumulation of HIF3A knockdown.
The amount of neutral lipids increased by 30% at day 13 but not day
10 of differentiation (Figure 3E). Finally, HIF3A knockdown had only
minor effects on adipocyte-specific genes. The expression of ADIPOQ
increased by 25% at day 6 while the expression of FABP4 was not
significantly affected (Figure 3F).
3.5. Analysis of previous clinically relevant associations for
lipolysis-associated genetic loci
We next assessed whether lipolysis-associated SNPs in the present
study were associated with obesesity-related clinical traits. None of the
suggestive lipolysis-associated SNPs were previously reported to be
associated with obesity (BMI, WHR, and % body fat) or related
metabolic traits (type 2 diabetes, insulin resistance, and plasma lipids)
according to the GWAS catalogue (https://www.ebi.ac.uk/gwas/,
20190410). However, a few SNPs were located in genes or within
þ/100 Kbps of SNPs reported to be associated with these traits, for
example, a locus on chromosome 2 harboring METAP1D was found to
be associated with % body fat [41] and loci on chromosome 15
(SLCO3A1) and 18 with BMI [8,42] (Supplementary Table 7).
3.6. Data mining of spontaneous or stimulated lipolysis loci
The SNPs displaying suggestive associations with spontaneous or
stimulated lipolysis were next investigated for genotype-specific gene
expression (or eQTLs). Among the SNPs represented in GTEx, the SNPs
associated with spontaneous lipolysis also demonstrated genotype-
specific expression patterns on chromosome 2 for PLGLB1 in the
SAT as well as on chromosome 19 for PPP5D1 in the brain and IGFL3
in the skin (Supplementary Table 4 and Supplementary Table 8). SNPs
in six loci associated with stimulated lipolysis demonstrated eQTLs.
The most interesting was rs9892812 on chromosome 17, which
influenced gene expression in the SAT of NUP85, GGA3, and MRPS7
(Supplementary Table 4 and Supplementary Table 8). Other notable
findings include rs11147005 on chromosome 12, the P2RX2 levels in
the visceral adipose tissue, and many SNPs on chromosome 10
influencing ATE1 levels in the skeletal muscle (Supplementary Table 4
and Supplementary Table 8). Brief descriptions of genes highlighted by
these analyses are presented in Supplementary Table 9. None of the
eQTL-associated genes have established roles in lipolysis regulation.an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 93
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example, the sample size, data collection time and method, and tissue
selection); however, these data are included to be as comprehensive
as possible.
4. DISCUSSION
In this first GWAS of human fat cell lipolysis, we identified one genetic
locus significantly associated with spontaneous lipolysis and multiple
additional loci with suggestive associations with spontaneous and
stimulated lipolysis. Furthermore, we provided evidence of HIF3A as a
candidate gene with a key role in regulating the expression of genes
central to lipolysis.
Regulation of SAT lipolysis is not well understood. Prior genetic studies
implicated coding variants in or near genes encoding proteins with
established and specific roles in lipolysis and glycerol release [43]. In
contrast, in this unique cohort, we identified the SNPs associated with
lipolysis that are not located in or near genes encoding proteins with
established roles in lipolysis. This is in line with studies of other
complex traits in which a GWAS of a well-defined phenotype can
highlight novel biology. That prior studies were not validated herein
suggests that they may represent spurious associations due to un-
derpowered study designs.
While several nominal loci were identified, for robustness, we focused
on the genome-wide significant locus on chromosome 19. This is a
gene-dense region with high LD. Among the genes in this locus, only
HIF3A was expressed in mature and precursor adipocytes and
constituted an eQTL and was thus the focus of further evaluation. We
provided functional support for transcription factor HIF3A explaining
the association between the chromosome 19 locus and lipolysis:
knockdown of HIF3A in hMSCs increased glycerol release and,
consistent with this, increased the expression of genes encoding the
major lipolysis-regulating lipases, that is, LIPE and PLNPLA2.
Furthermore, the major lipid droplet-coating protein in fat cells, PLIN1,
which is also critical for lipolysis, was influenced by HIF3A knockdown.
In agreement with an inhibitory effect of HIF3A on lipolysis, we
observed an inverse correlation between HIF3A expression and SAT
spontaneous lipolysis in women and borderline nominally significant
(P < 0.05) association with the rs73048031 genotype, whereby the
spontaneous lipolysis-decreasing allele (C) was associated with
increased HIF3A gene expression levels. We were unable to exclude
the possibility that genes encoding secreted proteins could control
lipolysis through distant-acting systemic effects, for example, IGFL3,
which is primarily expressed in the skin and comprises a cis-eQTL in
this organ for the lipolysis-associated SNPs on chromosome 19.
However, there was no evidence that IGFL3 was present in the general
circulation, making this scenario less likely.
The lipolysis-associated SNPs on chromosome 19 were not previ-
ously reported to be associated with clinical traits involving altered
lipolysis, for example, adiposity, insulin resistance, or dyslipidemia,
according to the GWAS catalogue. Furthermore, mice with a targeted
disruption of the HIF3A locus displayed cardiac and pulmonary
remodeling [44], but to the best of our knowledge, no phenotypes
related to altered lipid or glucose metabolism have been reported.
However, the HIF3A locus more generally has previously been
associated with lipoprotein subclasses in Finns [45], which might be
related to dysfunctional lipolysis. Furthermore, the influence of HIF3A
on lipolysis could go beyond the genetic effects. In addition to hyp-
oxia, HIF3A expression has also been reported to be regulated by the
anti-lipolytic hormone insulin [46]. Furthermore, SAT CpG methylation
of HIF3A has been associated with gene expression and BMI [47].94 MOLECULAR METABOLISM 34 (2020) 85e96  2020 The Author(s). Published by Elsevier GAlso, reported results supported the hypothesis that HIF3A methyl-
ation is secondary to, rather than causal of, obesity [48]. We cannot
exclude the possibility that the SNPs in the lipolysis-associated locus
influenced DNA methylation. HIF3A could possibly represent a
mechanistic link between obesity and metabolic complications since
SAT gene expression is inversely correlated with systemic insulin
resistance [49].
Hypoxia inducible factors (HIFs) are heterodimeric transcription factors
that regulate adaptive responses to low oxygen tension [50]. Ectopic
expression of HIF3A has been shown to enhance the adipogenic po-
tential in mouse fat cell line 3T3-L1 cells [51]. In this study, knockdown
of HIF3A did not suppress markers of adipocytes (FABP4 and ADIPOQ)
and increased lipid accumulation, suggesting that the effects are
species dependent. HIF3A binding motifs are not sufficiently well
described to determine via bioinformatics analyses whether HIF3A
directly represses LIPE, PNPLA2, and PLIN1. Experiments to address
this were beyond the scope of the present study.
How regulation of lipolysis is related to traits such as obesity and in-
sulin resistance is an area of obvious interest. However, the many loci
influencing metabolic traits likely act through a variety of different
mechanisms, with only a handful acting through lipolysis. Therefore,
the gold standard methods (genetic correlation and polygenic risk
scores) that consider the whole genome are inappropriate and could be
misleading. Consideration of specific loci could provide more accurate
estimates; however, defining the choice of loci is complex. For
example, only the loci with evidence of genotype-specific gene
expression patterns in adipose tissue could be considered, or with
supportive experimental data, but these methods are fraught with is-
sues. Expression data are limited in sample size, collection time points,
and tissue selection, to name only a few concerns. Similarly, only a
fraction of loci has been thoroughly studied experimentally. While this
information provides additional evidence, there is a significant amount
of bias that should be considered in their interpretation (while the
observed associations could be true, lack of associations cannot be
taken as true findings).
To date, lipolysis has not been extensively studied, and consensus in
methodology is lacking. The lipolysis measurements used in this study
were those most reflective of (best correlations with) clinical param-
eters. The limitations of this study include lack of replication, as we are
unaware of any other datasets with comparable phenotypes of suffi-
ciently large size to provide reasonable power for replication. The size
of the cohort might be the reason for only finding one genome-wide
significant locus for the lipolysis phenotypes. Nevertheless, the val-
idity of our findings is supported by first, consistent effects of sug-
gestive findings on the two phenotypes. That is, the effects on
spontaneous lipolysis were consistently the inverse of the effects on
stimulated lipolysis. Second, many SNPs showed effects on gene
expression in adult adipose tissues. Finally, manipulation of the
candidate gene expression levels in the GWAS-significant locus
demonstrated clear effects on lipolysis. HIF3A has multiple splice
variants, the expression of which are epigenetically regulated [52].
Whether there are also transcript-specific genetic effects on HIF3A
expression remains to be determined. Finally, this study was under-
powered for sex-specific analysis.
5. CONCLUSIONS
In conclusion, this first GWAS of adipocyte lipolysis identified a locus
on chromosome 19 that was significantly associated with sponta-
neous lipolysis, demonstrated that genetic regulation of spontaneous
and stimulated lipolysis overlaps, and provided evidence for HIF3AmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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as a strong candidate gene with a novel and key regulatory function
in SAT lipolysis in humans. We also highlighted multiple additional
genetic loci with suggestive associations with lipolysis, including
some that were previously linked to body fat storage and
distribution.
6. DATA AVAILABILITY
Summary statistics for the spontaneous and stimulated lipolysis GWAS
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